What are the first-line antibiotic treatments for an adult patient with non-peeling cellulitis, considering potential allergies to penicillin or cephalosporins, and possible methicillin-resistant Staphylococcus aureus (MRSA) involvement?

Treatment of Non-Purulent Cellulitis

First-Line Antibiotic Therapy

Beta-lactam monotherapy is the standard of care for typical uncomplicated non-purulent cellulitis, with a 96% success rate, and MRSA coverage is unnecessary in the absence of specific risk factors. 1

Recommended Oral Agents (Choose One):

• Cephalexin 500 mg orally every 6 hours 1, 2
• Dicloxacillin 250-500 mg every 6 hours 1, 2
• Amoxicillin (standard dosing) 1
• Penicillin V 250-500 mg four times daily 1
• Amoxicillin-clavulanate 875/125 mg twice daily 1

Treatment Duration:

Treat for exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 1 Traditional 7-14 day courses are no longer necessary for uncomplicated cases. 1

---

When to Add MRSA Coverage

Add MRSA-active antibiotics ONLY when specific risk factors are present: 1, 3

• Penetrating trauma or injection drug use 1
• Purulent drainage or exudate 1
• Known MRSA colonization or prior MRSA infection 1
• Systemic inflammatory response syndrome (SIRS) 1
• Athletes, prisoners, military recruits, long-term care facility residents 3

MRSA-Active Regimens:

For patients requiring MRSA coverage:

• Clindamycin 300-450 mg orally every 6 hours (provides single-agent coverage for both streptococci and MRSA, but use only if local MRSA clindamycin resistance is <10%) 1, 4
• Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily PLUS a beta-lactam (cephalexin or amoxicillin) 1, 4
• Doxycycline 100 mg orally twice daily PLUS a beta-lactam 1, 5

---

Penicillin/Cephalosporin Allergy Options

For patients with true penicillin and cephalosporin allergies:

• Clindamycin 300-450 mg orally every 6 hours (single-agent coverage for both streptococci and MRSA, if local resistance <10%) 1, 4
• Levofloxacin 500 mg daily for 5 days (reserve for beta-lactam allergies; lacks reliable MRSA coverage) 1
• Doxycycline 100 mg twice daily (must be combined with clindamycin for bite-related cellulitis in severe penicillin allergy) 1

Important: Cross-reactivity between penicillins and cephalosporins is only 2-4%, primarily based on R1 side chain similarity rather than the beta-lactam ring. 1 Cephalosporins with dissimilar side chains can be safely used in most penicillin-allergic patients. 1

---

Severe Cellulitis Requiring Hospitalization

For patients with systemic toxicity, rapid progression, or suspected necrotizing fasciitis, mandatory broad-spectrum combination therapy is required: 1

IV Regimens:

• Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
• Linezolid 600 mg IV twice daily PLUS piperacillin-tazobactam 1
• Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1

Treatment duration for severe cellulitis is 7-14 days, guided by clinical response. 1

---

Critical Evidence Against Routine MRSA Coverage

A landmark randomized controlled trial demonstrated that combination therapy with TMP-SMX plus cephalexin was no more efficacious than cephalexin alone for pure cellulitis without abscess, ulcer, or purulent drainage. 6 In this study, 85% of patients receiving combination therapy were cured versus 82% receiving cephalexin alone (risk difference 2.7%, 95% CI -9.3% to 15%, P=0.66). 6

However, in a retrospective cohort study from a high MRSA-prevalence area (Hawaii), antibiotics with activity against CA-MRSA (TMP-SMX, clindamycin) had significantly higher success rates than cephalexin alone (91% vs 74%, P<0.001). 7 This discrepancy highlights the importance of assessing for specific MRSA risk factors rather than reflexively adding MRSA coverage. 1

---

Essential Adjunctive Measures

• Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema 1
• Examine interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration and treat to eradicate colonization 1
• Address predisposing conditions: venous insufficiency, lymphedema, chronic edema, obesity, eczema 1

---

Common Pitfalls to Avoid

• Do not routinely add MRSA coverage for typical non-purulent cellulitis without specific risk factors – this represents overtreatment and increases antibiotic resistance 1
• Do not use doxycycline or TMP-SMX as monotherapy for typical cellulitis – their activity against beta-hemolytic streptococci is unreliable 1, 4
• Do not extend treatment to 10-14 days based on residual erythema alone – some inflammation persists even after bacterial eradication 1
• Reassess patients within 24-48 hours to verify clinical response, as treatment failure rates of 21% have been reported with some oral regimens 1

---

Special Populations

Breastfeeding Patients:

Clindamycin 300-450 mg orally three times daily is the preferred agent for breastfeeding women, providing excellent coverage for both MRSA and beta-hemolytic streptococci. 4 Avoid tetracyclines (doxycycline) when possible due to potential effects on infant bone development and dental staining. 4

Diabetic Foot Cellulitis:

Diabetic foot infections require broader coverage and longer duration. 1 For mild infections, use dicloxacillin, clindamycin, cephalexin, TMP-SMX, amoxicillin-clavulanate, or levofloxacin. 1 For moderate infections, use amoxicillin-clavulanate, levofloxacin, ceftriaxone, ampicillin-sulbactam, or ertapenem. 1